Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

Fri, 18th Jun 2021 13:12

LONDON, June 18 (Reuters) - AstraZeneca on Friday
said the European Union had lost a legal case against the
pharmaceutical firm over the supply of COVID-19 vaccines as a
court in Brussels rejected an EU request for more deliveries by
the end of June.

The Anglo-Swedish firm committed in a contract to do its
best to deliver to the 27-nation bloc 300 million doses by the
end of June, but production problems led the pharmaceutical
company to revise down its target to 100 million vaccines.

The cuts in the supplies delayed the EU's vaccination drive
in the first quarter of the year, when the bloc had initially
bet on AstraZeneca to deliver the largest volume of jabs. That
led to a bitter dispute and to the EU's legal action to get at
least 120 million doses by the end of June.

But the judge said the company should only deliver 80.2
million doses by a deadline of Sept. 27, AstraZeneca said.
(Reporting by Francesco Guarascio and Muvija M; writing by
Alistair Smout; editing by David Evans)

Related Shares

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.